brand:
DEPO-PROVERA®
origin:
The origin of this product is Europe
manufacturer:
Pfizer
active substances:
MEDROXYPROGESTERONE ACETATE
strength:
150mg/ml
pack size:
1 x 1ml Pre-Filled Syringe
other known names:
Other Known Names Depo-Provera® 150mg
accessories:
Accessories Package insert
DEPO-PROVERA® is an injectable form of medroxyprogesterone acetate, a synthetic hormone similar to progesterone. This medication is used primarily for contraception, but also for the management of certain cancers and endometriosis. Each injection provides three months of contraceptive protection, making it a convenient option for long-term use without daily or monthly administration.
DEPO-PROVERA® has several approved medical uses:
DEPO-PROVERA® is administered by injection, typically into the muscle of the buttock or upper arm. The dosage and frequency vary depending on the condition being treated:
It is essential that patients receive their injections on time to maintain the efficacy of the treatment, particularly in the case of contraception. If more than 14 weeks pass between injections, a pregnancy test may be required before administering the next dose.
Like all medications, DEPO-PROVERA® can cause side effects. Some are common and manageable, while others may be more severe and require immediate medical attention.
Patients should report any sudden loss of vision, severe abdominal pain, chest pain, or difficulty breathing to a healthcare provider immediately, as these may be signs of serious complications.
Certain medications can affect the efficacy of DEPO-PROVERA® or increase the risk of side effects. These include:
Patients should inform their healthcare provider of any medications they are currently taking, including over-the-counter drugs and supplements, to avoid potential drug interactions.
Clinical trials have demonstrated the efficacy of DEPO-PROVERA® as a contraceptive. It is 99.7% effective when administered every three months, making it one of the most reliable forms of birth control available. However, extended use can lead to a 1% failure rate, especially if injections are delayed beyond the recommended 12-week interval.
In addition to its use as a contraceptive, studies have shown that DEPO-PROVERA® can significantly reduce pain and the spread of endometrial tissue in women with endometriosis, with improvements typically seen after 6 months of treatment.
In cancer treatment, DEPO-PROVERA® has demonstrated effectiveness in slowing the growth of breast cancer, kidney cancer, and endometrial cancer, though it is not considered a cure for these conditions.
DEPO-PROVERA® should not be used by individuals with the following conditions:
Women who use DEPO-PROVERA® should also be aware that the medication does not protect against sexually transmitted infections (STIs), including HIV/AIDS. Safe sex practices, such as the use of condoms, should be followed to reduce the risk of STIs.